In the management of glaucoma, recent and upcoming innovations have the potential to contribute to both the efficacy of intraocular pressure (IOP) monitoring and the number of available treatment options. These new devices and procedures have two things in common: they are part of the trend in medicine towards miniaturization, and they require a limited surgical procedure to become effective. This review focuses on the Eyemate (Argos) intraocular sensor, which offers a new way to reliably measure 24 h IOP, and on intraocular sustained release systems for pharmacological glaucoma therapy. It also briefly reflects on the miniature implants currently used in minimally invasive glaucoma surgery (MIGS).
Keywords: Adherence; CyPass microstent; Eyemate (Argos) sensor; Glaucoma; Hydrus microstent; Intraocular drug delivery systems; Intraocular pressure (IOP); Minimally invasive glaucoma surgery (MIGS); XEN gel; iStent inject.